Holen Sie sich die Stockscreener-App
42.73
4.54%
-2.03
Schlusskurs vom Vortag:
$44.76
Offen:
$44.19
24-Stunden-Volumen:
256.40K
Relative Volume:
0.87
Marktkapitalisierung:
$3.25B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-14.54%
1M Leistung:
-10.98%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$41.50
$45.00
1-Wochen-Bereich:
$36.80
$52.01
52-Wochen-Spanne:
$9.95
$67.00
Jyong Biotech Ltd Stock (MENS) Company Profile
Firmenname
Jyong Biotech Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MENS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MENS
Jyong Biotech Ltd
|
42.73 | 3.40B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Jyong Biotech Ltd Aktie (MENS) Neueste Nachrichten
Jyong Biotech (NASDAQ:MENS) Shares Gap DownShould You Sell? - MarketBeat
Jyong Biotech (NASDAQ:MENS) Stock Price Up 11.2%Here's What Happened - MarketBeat
FLOWSERVE CORPORATION (FLS) Stock, Price, News, Quotes, Forecast and Insights - MSN
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday - Benzinga
Caterpillar, Nvidia Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com Nigeria
Caterpillar, Nvidia Lead Market Cap Stock Movers on Wednesday - Investing.com India
Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results - Yahoo Finance
Jyong Biotech (NASDAQ:MENS) Stock Price Down 15.6%Here's Why - MarketBeat
Tesla and Nvidia lead market cap stock movers this Tuesday - Investing.com
Here's How Much Traders Expect Meta Stock To Move After Earnings This Week - Yahoo Finance
Tesla and Qualcomm Lead Monday’s Market Cap Stock Movers - Investing.com
Tesla and Qualcomm Lead Monday’s Market Cap Stock Movers By Investing.com - Investing.com UK
New Montreal Biotech LifeLore Pathways Launches to Accelerate Microbial Innovation - Yahoo Finance
Jyong Biotech's (MENS) "Sell (E+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
PCI Biotech update - Yahoo Finance
Jyong Biotech (NASDAQ:MENS) Stock Price Up 5.8%What's Next? - MarketBeat
Bitcoin Mining Profitability Declined More Than 7% in September: Jefferies - Yahoo Finance
FDA Grants First CNPV Vouchers, Igniting Rally in Biotech Stocks - Yahoo Finance
Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO - Yahoo Finance
KBR Announces Dividend Declaration - Yahoo Finance
UPS To Release Third-Quarter 2025 Results On Tuesday, October 28, 2025 - Yahoo Finance
Jim Cramer on Inspire Medical: “They’ve Had One Execution Issue After Another” - Yahoo Finance
LEIFRAS Co., Ltd. Announces Pricing of Initial Public Offering - Yahoo Finance
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400% - Benzinga
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400% - Sahm
Jyong Biotech (NASDAQ:MENS) Stock Price Down 4.4%What's Next? - MarketBeat
Q3 Western IPO Activity Centers On US But Offerings Are Rising In The East - Citeline News & Insights
CCTV4: Heritage and Harmony Beneath the Full Moon, The World Is Invited to the CMG 2025 Mid-Autumn Festival Gala - Yahoo Finance
Jyong Biotech (NASDAQ:MENS) Trading 6.5% HigherWhat's Next? - MarketBeat
Eli Lilly, Merck Surge Among Wednesday’s Market Cap Stock Movers - Investing.com
Jyong Biotech (NASDAQ:MENS) Shares Down 8%What's Next? - MarketBeat
RBC Capital Reiterates a Buy Rating on Legend Biotech Corporation (LEGN) - Yahoo Finance
Jyong Biotech Wins Innovation Gold Award in Pharmaceutical Category at 2025 Taipei Biotech Awards - GlobeNewswire
First Taiwan-Developed Botanical Drug in FDA Phase III: Jyong Biotech Wins Gold for BPH Treatment - Stock Titan
The Biotech Stock That's Too Risky for Most Investors - Yahoo Finance
Moleculin Biotech announces issuance of Canadian patent covering Annamycin - Yahoo Finance
Kardigan Advances Late-Stage Portfolio of Personalized Cardiovascular Medicines in Dilated Cardiomyopathy, Acute Severe Hypertension and Calcific Aortic Valve Stenosis - Yahoo Finance
Jyong Biotech (NASDAQ:MENS) Trading Down 6.1%Here's Why - MarketBeat
Kneat Recognised as Leader in G2 Pharma and Biotech Fall 2025 Grid Reports - Yahoo Finance
Tesla and Uber Lead Market Cap Stock Movers on Monday By Investing.com - Investing.com South Africa
Tesla and Uber Lead Market Cap Stock Movers on Monday - Investing.com India
MENS Stock Price and Chart — NASDAQ:MENS - TradingView
Jyong Biotech (NASDAQ:MENS) Reaches New 52-Week HighStill a Buy? - MarketBeat
Jyong Biotech (NASDAQ:MENS) Shares Gap UpHere's Why - MarketBeat
Sana Biotechnology Inc. (SANA) Bolsters Management Team - Yahoo Finance
Jyong Biotech Chairwoman and CEO Set to Attend as Speaker at 2025 Global Business Forum in Taipei - GlobeNewswire
Taiwan Biotech Leader Joins Global Business Forum: Jyong CEO to Discuss Cross-Border Innovation - Stock Titan
Jim Cramer Says Apple Inc. (AAPL)’s Going To Have The Best AI - Yahoo Finance
Jyong Biotech (NASDAQ:MENS) Stock Price Down 4.7%Should You Sell? - MarketBeat
Jyong Biotech completes patient enrollment in Phase II trial of MCS-8 - TipRanks
Jyong Biotech Announces Completion of Patient Enrollment of - GlobeNewswire
Finanzdaten der Jyong Biotech Ltd-Aktie (MENS)
Es liegen keine Finanzdaten für Jyong Biotech Ltd (MENS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):